The Cooper Companies, Inc. (NASDAQ:COO) shares fell 15.96% in after-hours trading Wednesday after the company reported fiscal third-quarter results, announced the completion of its strategic review, and issued fiscal fourth-quarter and full-year guidance.
The stock closed Wednesday’s regular session down 6.22% at $63.48. It then fell 15.96% to $53.35 in after-hours trading.
Cooper Companies is a global medical device company operating through two business units: CooperVision, focused on contact lenses, and CooperSurgical, focused on fertility and women’s healthcare.
Third Quarter Fiscal 2026
Revenue rose 1% year over year to $1.066 billion. Non-GAAP diluted EPS came in at $1.15, up 4% from a year ago. CooperVision revenue was flat, with Americas sales down 2% and Asia Pacific down 5% organically. CEO Al White said reduced U.S. channel inventory weighed on results and is expected to continue impacting the fourth quarter. CooperSurgical revenue grew 3% organically.
Read Also: Bill Ackman Calls Anthropic Researcher's Exit 'Interesting' Amid Claims of 'Well-Funded PR Operation' Aimed at Democrats
Fourth Quarter and Fiscal 2026 Guidance
Cooper Companies expects fourth-quarter revenue of $1.057 billion to $1.080 billion and non-GAAP diluted EPS of $1.05 to $1.09. For full fiscal 2026, the company expects revenue of $4.229 billion to $4.252 billion and non-GAAP diluted EPS of $4.51 to $4.55.
Strategic Review
The company completed its strategic review, first announced in December 2025, during which the Board evaluated a possible sale of CooperSurgical. The Board unanimously concluded that shareholders would be better served by retaining CooperSurgical rather than pursuing a transaction. The Board also approved expanding its share repurchase authorization from $2 billion to $3 billion.
Trading Metrics
Cooper Companies has a market capitalization of $12.38 billion.
The stock has a 52-week high of $89.83 and a 52-week low of $58.89.
Cooper Companies shares are down 6.18% over the past year.
Benzinga’s Edge Stock Rankings show a negative price trend across the short-, medium- and long-term time frames.
See More: Top Growth Stocks
Disclaimer: This content was produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo: Who is Danny / Shutterstock